Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 11, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 13, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001639691-26-000015
Filed / recorded
Mar 13, 2026, 9:25 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
LivaNova PLC
Issuer CIK
1639691
Ticker
LIVN
Reporting person
Franco Poletti
Relationship
Officer
Officer title
President, Cardiopulmonary
Security
Stock Appreciation Rights
Table
Derivative (Table II)
Transaction date
Mar 11, 2026
Transaction code
M
Shares / units
2,140
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Direct
Amendment
No
Footnotes from the filing
Reporting person was granted SARs on March 11, 2016 that vested in four equal annual installments beginning March 11, 2017 under the LivaNova PLC 2015 Incentive Award Plan and were automatically exercised upon their March 11, 2026 expiration date.